Clinical Trial Update: Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries

View source ↗

Summary

A clinical trial is exploring predicting germline BRCA1/2 gene status from healthy ovarian tissue and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Breast and Ovarian Cancer Syndrome
• Ovarian Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: BRCA Mutation, Ovarian Cancer | Status: RECRUITING